Report of Foreign Issuer (6-k)

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of August, 2017

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _______ No ___X____

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In July 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. ⁽¹⁾

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.							CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾				Quantity			%
								Same Class and Type			Total
Shares	Common				10,438,917			0.0664			0.0664
Transac tions in the month
Securities / Derivatives	Securities Characteristics ⁽²⁾	Intermediary	Operation	Day		Quantity			Price	Volume (R$) ⁽³⁾
Shares	Common	Direct with the Company	Conversion in ADRs	28		19,304			0.00	0.00
Shares	Common	Direct with the Company	Conversion in ADRs	31		24,157			0.00	0.00
			Total Conversion ADRs (Out)			43,461				0.00
Shares	Common	Direct with the Company	Exerc Options	03		46,000			3.120960	143,564.16
Shares	Common	Direct with the Company	Exerc Options	11		30,125			9.359600	281,957.95
Shares	Common	Direct with the Company	Exerc Options	11		25,385			11.972000	303,909.22
Shares	Common	Direct with the Company	Exerc Options	31		212,039			2.462738	522,196.63
Shares	Common	Direct with the Company	Exerc Options	31		59,750			1.296480	77,464.68
Shares	Common	Direct with the Company	Exerc Options	31		38,080			11.972000	455,893.76
			Total Sell			411,379				1,784,986.40

Shares	Common	Direct with the Company	Plan of Shares Acquisition	03		7,854			18.28	143,571.12
Shares	Common	Direct with the Company	Plan of Shares Acquisition	07		4,477			18.02	80,675.54
Shares	Common	Direct with the Company	Plan of Shares Acquisition	11		31,635			18.52	585,880.20
Shares	Common	Direct with the Company	Plan of Shares Acquisition	31		23,807			19.15	455,904.05
			Total Buy			67,773				1,266,030.91
Final Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾				Quantity			%
								Same Class and Type			Total
Shares	Common				10,051,850			0.0640			0.0640

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price .

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In July 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. ⁽¹⁾

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.							CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾				Quantity			%
								Same Class and Type			Total
ADR ^(*)	Common				0			0.0000			0.0000
Transac tions in the month
Securities / Derivatives	Securities Characteristics ⁽²⁾	Intermediary	Operation	Day		Quantity			Price USD	Volume (USD) ⁽³⁾

ADR ^(*)	Common	Direct with the Company	Conversion in ADRs	28		19,304			0.0000	0.00
ADR ^(*)	Common	Direct with the Company	Conversion in ADRs	31		24,157			0.0000	0.00
			Total Conversion ADRs (In)			43,461

ADR ^(*)	Common	Direct with the Company	Plan of Shares Acquisition	28		136,416			6.05	825,316.00
ADR ^(*)	Common	Direct with the Company	Plan of Shares Acquisition	31		9,193			6.08	55,894.60
			Total Buy			145,609				881,210.60


ADR ^(*)	Common	Direct with the Company	Exerc Options	28		155,720			5.300	825,316.00
ADR ^(*)	Common	Direct with the Company	Exerc Options	31		33,350			1.676	55,894.60
			Total Sell			189,070				881,210.60

Final Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾				Quantity			%
								Same Class and Type			Total
ADR ^(*)	Common				0			0.0000			0.0000

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price .

(*) Each ADR is equivalent to 1 (one) share.

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In July 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. ⁽¹⁾

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Subsidiary Name: Ambev Luxembourg S.À.R.L.
Qualification: Position – Total Return Swap
Transac tions in the month
Securities / Derivatives	Securities Characteristics ⁽¹⁾	Intermediary	Operation	Day ^(*)	Quantity ^(**)	Price USD	Volume (USD) ⁽²⁾
Swap	Swap referenced in Shares	N/A	Total Return Swap Conclusion	31	1,775,000	19.1999	34,079,822.50
			Total operation		1,775,000		34,079,822.50

(1) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(2) Quantity multiplied by price .

(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

(**) The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: August 10, 2017